Professor of Health Economics & Director, HERC
- Professor of Health Economics, University of Oxford
- Academic, Melbourne School of Population and Global Health
- Honorary, Melbourne Institute of Applied Economic and Social Research
Professor Philip Clarke re-joined HERC in August 2018 after previous appointments at the Universities of Sydney and Melbourne in Australia. He is a Fellow of the Academy of the Social Sciences in Australia (ASSA).
His research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. Philip has been involved in the development of the UKPDS Outcomes Model, a health economic simulation model for type 2 diabetes.
The comparative mortality of an elite group in the long run of history: an observational analysis of politicians from 11 countries
Clarke PM. et al, (2022), European Journal of Epidemiology
A randomized controlled trial to test financial incentives for COVID- 19 vaccination in Ghana
Duch R., (2022), Nature Medicine
Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations.
Duch R. et al, (2022), Proc Natl Acad Sci U S A, 119
Patient and clinician characteristics and preferences for increasing participation in placebo surgery trials: a scoping review of attributes to inform a discrete choice experiment.
Hinwood M. et al, (2022), Trials, 23
Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1·95 million events in 80·4 million people in four countries.
Camacho X. et al, (2022), Lancet Public Health, 7, e229 - e239